[Effect of surface modification on surface energy of lactose and performance of dry powder inhalations]
- PMID: 16011271
[Effect of surface modification on surface energy of lactose and performance of dry powder inhalations]
Abstract
Aim: To investigate the effects of surface modification of lactose carrier on performance of dry powder inhalations (DPIs).
Methods: Modified lactose surface was prepared using a "particle smoothing" process to obtain smooth carrier surface and low surface energy with the presence of magnesium stearate, colloidal silica dioxide and talc. Inverse gas chromatography (IGC) was used to assess the surface energy of treated lactose, and the in vitro deposition of carrier-based IFNa-2b DPIs was evaluated with twin stage impinger.
Results: The flowing property of lactose was greatly improved and the surface energy decreased by the "particle smoothing" process. Decreasing surface energy resulted in greater aspiration fraction of IFNa-2b.
Conclusion: IGC is a potentially useful tool for rapid formulation design and screening.
Similar articles
-
Use of recrystallized lactose as carrier for inhalation powder of interferon a2b.Pharmazie. 2005 Aug;60(8):632-3. Pharmazie. 2005. PMID: 16124411
-
Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.Chem Pharm Bull (Tokyo). 2004 Mar;52(3):350-3. doi: 10.1248/cpb.52.350. Chem Pharm Bull (Tokyo). 2004. PMID: 14993760
-
Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".J Pharm Pharmacol. 2002 Oct;54(10):1339-44. doi: 10.1211/002235702760345400. J Pharm Pharmacol. 2002. PMID: 12396294
-
The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalers.Adv Drug Deliv Rev. 2012 Mar 15;64(3):285-93. doi: 10.1016/j.addr.2011.12.015. Epub 2012 Jan 13. Adv Drug Deliv Rev. 2012. PMID: 22265843 Review.
-
Lactose characteristics and the generation of the aerosol.Adv Drug Deliv Rev. 2012 Mar 15;64(3):233-56. doi: 10.1016/j.addr.2011.05.003. Epub 2011 May 13. Adv Drug Deliv Rev. 2012. PMID: 21616107 Review.
Cited by
-
Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.AAPS PharmSciTech. 2014 Dec;15(6):1417-28. doi: 10.1208/s12249-014-0166-z. Epub 2014 Jun 25. AAPS PharmSciTech. 2014. PMID: 24962007 Free PMC article.